BiotechTube

Sulopenem etzadroxil/probenecid + Amoxicillin/clavulanate

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Urinary Tract Infections

Conditions

Urinary Tract Infections, Cystitis

Trial Timeline

Oct 18, 2022 → Nov 21, 2023

NCT ID
NCT05584657

About Sulopenem etzadroxil/probenecid + Amoxicillin/clavulanate

Sulopenem etzadroxil/probenecid + Amoxicillin/clavulanate is a phase 3 stage product being developed by Iterum Therapeutics for Urinary Tract Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT05584657. Target conditions include Urinary Tract Infections, Cystitis.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT05584657Phase 3Completed

Competing Products

20 competing products in Urinary Tract Infections

See all competitors
ProductCompanyStageHype Score
Duloxetine + placeboEli LillyPhase 2
52
DuloxetineEli LillyPhase 2
52
Enfortumab vedotinAstellas PharmaPhase 1
33
solifenacin succinate + tamsulosin + placeboAstellas PharmaApproved
85
solifenacin succinate + tamsulosin hydrochloride + Placebo to solifenacin + Placebo to tamsulosinAstellas PharmaPhase 2
52
SolifenacinAstellas PharmaApproved
85
Mirabegron + Tolterodine + Placebo to Mirabegron + Placebo to TolterodineAstellas PharmaPhase 3
77
Levofloxacin + Solifenacin succinate + Placebo (for Solifenacin succinate)Astellas PharmaApproved
85
solifenacin succinateAstellas PharmaPhase 3
77
SolifenacinAstellas PharmaPre-clinical
23
SolifenacinAstellas PharmaPre-clinical
23
TamuslosinAstellas PharmaPhase 3
77
Tamsulosin + SolifenacinAstellas PharmaApproved
85
Alpha blocker + placebo + solifenacinAstellas PharmaApproved
85
mirabegron 25 mg + mirabegron 50 mg + solifenacin 5 mg + solifenacin 10 mg + mirabegron 25 mg matching placebo + mirabegron 50 mg matching placebo + solifenacin 5 mg matching placebo + solifenacin 10 mg matching placeboAstellas PharmaPhase 3
77
solifenacin succinate + tolterodineAstellas PharmaPhase 3
77
TamusulosinAstellas PharmaPhase 3
77
SolifenacinAstellas PharmaPre-clinical
23
Solifenacin succinate + TolterodineAstellas PharmaPhase 3
77
Solifenacin succinate + PlaceboAstellas PharmaPhase 3
77

Other Products from Iterum Therapeutics

CiprofloxacinApproved
77
Sulopenem-Etzadroxil/Probenecid + CiprofloxacinPhase 3
69
Sulopenem + Sulopenem-Etzadroxil/Probenecid + Ertapenem + Ciprofloxacin + Amoxicillin-clavulanatePhase 3
69
Ertapenem + Sulopenem-Etzadroxil/Probenecid + Ciprofloxacin + Metronidazole + Amoxicillin-Clavulanate + SulopenemPhase 3
69
Azithromycin plus hydroxychloroquinePhase 3
69